Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
ISIS-2 - 4-YEAR MORTALITY FOLL...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
ISIS-2 - 4-YEAR MORTALITY FOLLOW-UP OF 17,187 PATIENTS AFTER FIBRINOLYTIC AND ANTIPLATETLET THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION
Bibliographic Details
Main Authors:
Baigent, C
,
Collins, R
Format:
Journal article
Published:
1993
Holdings
Description
Similar Items
Staff View
Similar Items
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
by: Collins, R, et al.
Published: (1997)
Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
by: Collins, R, et al.
Published: (1997)
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.
by: Appleby, P, et al.
Published: (1994)
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
by: Baigent, C, et al.
Published: (1998)
LATE BENEFIT AND EARLY HAZARD ASSOCIATED WITH FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM 6 LARGE RANDOMIZED CONTROLLED TRIALS
by: Baigent, C
Published: (1992)